Ascendis Pharma (ASND) issues 27,030 employee warrants at $213.23 exercise price
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Ascendis Pharma A/S reported granting new equity incentives to employees through a warrant program. On June 9, 2026, the board approved a total of 27,030 warrants under Appendix 1a of the company’s Articles of Association, and amended the Articles to allow this grant.
Each warrant allows the holder to subscribe for one ordinary share at an exercise price of US $213.23 per share, matching the closing share price on the grant date. Vesting is time-based: 25% vests on the one-year anniversary of the grant and the remaining 75% vests in equal monthly installments over the following 36 months, subject to continued service and certain earlier-vesting exit events.
After this grant, warrants to subscribe for an additional 1,553,563 shares remain available for future grants under the company’s Articles of Association.
Positive
- None.
Negative
- None.
Key Figures
Warrants granted: 27,030 warrants
Exercise price: US $213.23 per share
Remaining warrant pool: 1,553,563 shares
+2 more
5 metrics
Warrants granted
27,030 warrants
Granted to certain employees on June 9, 2026
Exercise price
US $213.23 per share
Equal to closing price on grant date
Remaining warrant pool
1,553,563 shares
Warrants still available for future grants after this award
Initial vesting tranche
25% of warrants
Vests on one-year anniversary of grant date
Ongoing vesting
75% over 36 months
Monthly vesting starting one year after grant, with continued service
Key Terms
Form 6-K, warrants, Articles of Association, exercise price, +1 more
5 terms
Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
warrants financial
"the Company’s board of directors granted an aggregate of 27,030 warrants to certain employees"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
Articles of Association regulatory
"under the terms of Appendix 1a to the Company’s Articles of Association"
A company's articles of association are its written rulebook that sets how the business is run, how decisions are made, and what rights owners and directors have—covering voting, meetings, appointment and removal of directors, share classes and dividend policies. For investors, these rules matter because they determine how easily control can change, what protections minority owners have, and how corporate actions (like issuing new shares or changing leadership) are approved, much like a home’s bylaws shaping what residents can and cannot do.
exercise price financial
"has an exercise price equal to US $213.23 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the Warrants will vest on the one year anniversary of the date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did Ascendis Pharma (ASND) disclose in its June 2026 Form 6-K?
Ascendis Pharma disclosed that its board granted 27,030 employee warrants on June 9, 2026. These equity awards are issued under Appendix 1a of its Articles of Association, with related amendments to permit the new grant.
How many warrants did Ascendis Pharma (ASND) grant and to whom?
The company granted an aggregate of 27,030 warrants to certain employees. Each warrant entitles the holder to subscribe for one ordinary share, serving as an equity-based incentive aligned with the company’s long-term performance.
What is the exercise price of the new Ascendis Pharma (ASND) warrants?
Each new warrant has an exercise price of US $213.23 per share. This price equals the closing market price of Ascendis Pharma’s ordinary shares on the June 9, 2026 grant date.
How do the Ascendis Pharma (ASND) employee warrants vest over time?
Twenty-five percent of the warrants vest one year after the grant date, with the remaining 75% vesting monthly over 36 months. Vesting requires continued service and may accelerate upon certain exit events described in company documents.
How many additional Ascendis Pharma (ASND) warrants remain available for future grants?
After this grant, warrants to subscribe for an additional 1,553,563 shares remain available. These can be granted by the board in the future pursuant to the company’s Articles of Association.
Where are the detailed terms of the Ascendis Pharma (ASND) warrants described?
The material terms of the warrants are set out in Ascendis Pharma’s Articles of Association. That document is filed as Exhibit 1.1 and incorporated by reference into this Form 6-K report.